Physician review
Prescription decisions begin with medical-history and contraindication review by Dr. Anjmun Sharma, MD.
If you carry weight around your middle, crash after meals, or have been told you're "pre-diabetic," insulin resistance may be driving the problem. Here's how a medically supervised metabolic reset helps.

Insulin resistance can make weight management harder, and treatment should account for glucose history, current medications, and individual risk. New Hope may consider compounded semaglutide or tirzepatide after physician review. Compounded medications are not FDA-approved or brand-identical, and results vary. The published physician review is $119; medication is billed separately.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Costs less than your daily coffee.
$166 a month, physician-supervised, no insurance needed.
When cells stop responding well to insulin, your pancreas pumps out more of it. High insulin tells the body to store fat, especially around the abdomen, and makes it very hard to burn. It also drives hunger and energy crashes. The cruel irony: the more insulin-resistant you become, the harder weight loss gets, which worsens insulin resistance further.
GLP-1 medications improve the body's blood-sugar regulation and reduce the appetite spikes that come with insulin swings. Semaglutide and tirzepatide were originally developed in the diabetes world precisely because they help with glucose control, and that same mechanism makes them powerful tools against insulin-resistance-driven weight gain.
Dr. Sharma evaluates your metabolic picture and builds a plan that pairs GLP-1 therapy with practical nutrition guidance focused on protein and lower glycemic load. Start with the 2-minute quiz.
Insulin resistance drives fat storage and hunger, making weight loss very hard. GLP-1 medications improve blood-sugar regulation and reduce appetite swings, directly targeting the mechanism. Combined with protein-focused, lower-glycemic nutrition, they help break the cycle under physician supervision.
GLP-1 receptor agonists were developed for blood-sugar control and improve glucose regulation as well as supporting weight loss. Improved insulin sensitivity often follows weight loss. Dr. Sharma supervises your program and monitors progress.
GLP-1 therapy is commonly used in patients with pre-diabetes and insulin resistance. Dr. Sharma reviews your full history and labs (where available) and supervises dosing. People with type 1 diabetes or certain conditions are screened out during intake.
At New Hope Weight Loss, a metabolic reset means addressing the hormonal drivers of weight, insulin resistance and appetite, with physician-supervised GLP-1 therapy plus targeted nutrition, rather than relying on calorie restriction alone.
From about $5.50 a day, less than a daily latte
A fraction of brand-name GLP-1 list prices, which often run $900 to $1,300 or more a month.
$119 one-time to get started with your physician consultation.
Medical disclaimer: Individual results may vary. GLP-1 medications require a physician prescription and ongoing supervision. Clinical trial results cited are averages; not all patients achieve the same outcomes. Eligibility is determined during the medical consultation. This information does not replace professional medical advice.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.